Interpace Diagnostics Changes Name to Interpace Biosciences; Announces Plans for Next Phase of Growth and Third Quarter 2019 Financial Results
Go back to Interpace Diagnostics Changes Name to Interpace Biosciences; Announces Plans for Next Phase of Growth and Third Quarter 2019 Financial Results| (AMEX: IDXG) | Delayed: 1.68 +0.05 (3.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.63 | 52 Week High | $0.64 | |||
| Open | $1.63 | 52 Week Low | $0.10 | |||
| Day High | $1.68 | P/E | N/A | |||
| Day Low | $1.63 | EPS | $0.00 | |||
| Volume | 230 | |||||

